19:29 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNX
I'm PortAI, I can summarize articles.
Pomerantz Law Firm is investigating claims on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX) regarding potential securities fraud or unlawful business practices by the company and its officers. Following a report of a 36% year-over-year increase in new patient starts, Beta Bionics' stock price fell by 37.03% to $20.15 per share. Investors are encouraged to contact Pomerantz for more information about joining the class action.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments